Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Leukemia
|
April 22, 2005
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
R F Schlenk, U Germing, F Hartmann, et al.
ACS Nano
|
May 14, 2015
Basal-Plane Functionalization of Chemically Exfoliated Molybdenum Disulfide by Diazonium Salts
Kathrin C Knirsch, Nina C Berner, Hannah C Nerl, et al.
British Journal of Haematology
|
September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group
M Hallek, B Schmitt, M Wilhelm, et al.
Blood
|
November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure
R Hehlmann, A Hochhaus, H J Kolb, et al.
Leukemia
|
January 27, 2006
Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial
R F Schlenk, S Fröhling, F Hartmann, et al.
Immunobiology
|
March 1, 1983
Statement on the nomenclature of human C4 allotypes
G Mauff, C A Alper, Z Awdeh, et al.
Leukemia
|
October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C
M C Müller, N Gattermann, T Lahaye, et al.
Leukemia
|
February 10, 2016
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
M B Miranda, M Lauseker, M-P Kraus, et al.
Leukemia
|
July 30, 2003
Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea
R Hehlmann, U Berger, M Pfirrmann, et al.
Leukemia
|
October 15, 2015
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
A Gratwohl, M Pfirrmann, A Zander, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Leukemia
|
April 22, 2005
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
R F Schlenk, U Germing, F Hartmann, et al.
ACS Nano
|
May 14, 2015
Basal-Plane Functionalization of Chemically Exfoliated Molybdenum Disulfide by Diazonium Salts
Kathrin C Knirsch, Nina C Berner, Hannah C Nerl, et al.
British Journal of Haematology
|
September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group
M Hallek, B Schmitt, M Wilhelm, et al.
Blood
|
November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure
R Hehlmann, A Hochhaus, H J Kolb, et al.
Leukemia
|
January 27, 2006
Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial
R F Schlenk, S Fröhling, F Hartmann, et al.
Immunobiology
|
March 1, 1983
Statement on the nomenclature of human C4 allotypes
G Mauff, C A Alper, Z Awdeh, et al.
Leukemia
|
October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C
M C Müller, N Gattermann, T Lahaye, et al.
Leukemia
|
February 10, 2016
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
M B Miranda, M Lauseker, M-P Kraus, et al.
Leukemia
|
July 30, 2003
Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea
R Hehlmann, U Berger, M Pfirrmann, et al.
Leukemia
|
October 15, 2015
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
A Gratwohl, M Pfirrmann, A Zander, et al.
Page
of 8